Comparative Evaluation of Serum Homocysteine in Patients with Oral Submucous Fibrosis and Healthy Controls Authors: Shilpa Shastri, Santosh Kumar, Thousif Ahmed, Singamsetty S. Madhavi, Aaron Karthik, Awaiz Ahmed Published: 2025 ABSTRACT Background:Oral submucous fibrosis (OSMF) is a potentially malignant, persistent, and progressive condition that is closely linked with the use of areca nut. As the prevalence and malignant potential of OSMF continue to rise, it is urgently necessary to develop some reliable biomarkers of progression and prognostication.Materials and Methods:The study was a case-control study based on 60 individuals: 30 individuals who had OSMF and 30 age and sex-appropriate healthy persons as controls. Histopathological grading and clinical staging were carried out according to the standardized criteria. Measurements of serum homocysteine were performed by the competitive chemiluminescent immunoassay. Statistical analysis of data was calculated based on SPSS version 20.0; contrasts were done by t-tests, F-tests, and one-way ANOVA.Results:Serum level of homocysteine in the OSMF patients was higher compared to that of the controls, with a mean of 37.02 (4.84 mmol/L; P < 0.01) in the OSMF group and 22.55 (2.52 mmol/L) in the controls. There was a significant elevation of homocysteine with the increasing clinical stages and grading of histopathological stages of OSMF.Conclusion:Among OSMF patients, the clinical and histopathological severity of this disease is positively related to increased serum homocysteine. As part of prognostic biomarkers, homocysteine could be used in the early detection and management of progression of OSMF at a minimal cost and with minor invasiveness. INTRODUCTION Oral submucous fibrosis (OSMF) is a potentially malignant, chronic, and progressive disease of the oral cavity with inflammation and fibrotic changes in the submucosal tissues of the oral cavity. It causes the limitation of mouth opening and a burning feeling, as well as stiffness of the oral mucosa, which seriously affects the quality of life of the patient. The sickness usually affects the buccal mucosa, tongue, soft palate, and upper one-third of the esophagus, and in severe cases results in loss of taste sensation and dysfunction of the Eustachian tubes.[1] OSMF is a significant health issue in India, with a prevalence rate of 0.03-6.42% indicating about 5 million affected persons. This increase has been classified to be mainly caused by the high use of areca nut and other commercial products like pan masala, especially by the young people.[2] OSMF has multifactorial etiology, including chewing of areca nut, nutritional deficiencies, and genetic causes of OSMF. This change in epithelial reaction with irritating compounds, such as capsaicin, alkaloids in areca nut, is precipitated by nutritional deficiencies of iron and particular vitamins like B-complex; this starts a chain reaction of inflammation and fibrosis.[3] Clinically, OSMF manifests itself in the first place manifested by burning sensations and intolerability of spicy food, followed by blanching of the mucosa, the development of fibrotic bands, and impaired oral functions, such as speech and swallowing. The disease is also ineffective to treatment and has high chances of malignant change, which has led to the divergent need to find reliable biomarkers that could be used to predict the disease progression as well as risk of malignancy, which is reported to have a range of 7-30%.[4] New developments in metabolomics have enabled the possibility of discovering biochemical markers, such as plasma free amino acids (PFAAs), which change in pathological conditions, such as in the case of cancer. Of these, homocysteine, a nonessential amino acid that contains sulfur, is becoming a concern as it is highly associated with the vitamin B12, folic acid, and B6 status. High serum homocysteine is associated with various epithelial dysplasias and cancerous disorders, and the analysis of the level by means of various methods, such as HPLC and immunoassays, is a cheap and economically nonobtrusive alternative in diagnosis.[5] MATERIALS AND METHODS A total of 60 subjects were enrolled, including 30 clinically and histopathologically confirmed cases of oral submucous fibrosis (OSMF) and 30 healthy individuals without systemic illnesses as controls. Patients were categorized into three clinical stages based on the criteria proposed by Bailoor and Nagesh. A detailed case history, habit assessment, and clinical examination were recorded using a structured proforma, and informed written consent was obtained. All subjects underwent standardized clinical examination, which included measurements of mouth opening (interincisal distance), tongue protrusion, and cheek flexibility. These measurements were taken thrice and averaged. Clinical staging was followed by incisional biopsy of the buccal mucosa in OSMF patients and in control subjects undergoing minor oral surgical procedures. Tissue specimens were fixed in 10% neutral buffered formalin, sectioned at 5 µm thickness, and stained with hematoxylin and eosin for histopathological grading based on Pindborg’s classification. Four histological grades were defined, ranging from Grade I (very early stage) to Grade IV (advanced stage), depending on the extent of fibrosis and cellular changes. For biochemical analysis, 3 mL of venous blood was drawn from each participant, allowed to clot, centrifuged, and the serum was separated. Serum homocysteine levels were measured using the competitive chemiluminescent immunoassay technique on the ADVIA Centaur Autoanalyzer. Data were statistically analyzed using SPSS version 20.0 software. RESULTS The study comprised 60 individuals equally divided into the OSMF group and healthy controls. Both groups had comparable mean ages (~24.5 years) and similar male predominance (90%). Gutkha chewing emerged as the most prevalent habit among OSMF patients (50%). Significantly higher mean serum homocysteine levels were observed in the OSMF group (37.02 ± 4.84 µmol/L) compared to controls (22.55 ± 2.52 µmol/L), with P < 0.01 indicating high statistical significance. Furthermore, serum homocysteine levels increased progressively with advancing clinical stages (Stage I: 33.05 µmol/L to Stage III: 42.30 µmol/L) and histopathological grades (Grade I: 32.66 µmol/L to Grade IV: 44.57 µmol/L), both with P < 0.01. This suggests a strong positive correlation between homocysteine concentration and disease severity in OSMF [Tables 1 and 2]. Table 1Comparison of serum homocysteine levels between groups and within clinical stages and histological Grades of OSMFGroup/Stage/GradeNumber of PatientsMean Homocysteine (μmol/L)±SDRange (μmol/L)Statistical SignificanceControl group3022.55±2.5218.24–26.76Reference groupOSMF group (Overall)3037.02±4.8428.45–46.47t=14.524, P<0.01Stage I (mild)1033.05±3.1228.45–38.17Stage II (moderate)1035.72±2.0132.42–38.28Stage III (severe)1042.30±3.3836.53–46.47F=26.983, P<0.01Grade I1232.66±2.3528.45–36.66Grade II1037.07±1.1635.33–38.41Grade III240.34±0.2640.16–40.53Grade IV644.57±1.7842.66–46.47F=57.818, P<0.01 Comparison of serum homocysteine levels between groups and within clinical stages and histological Grades of OSMF Table 2Distribution of demographic and habitual variables in OSMF and control groupsParameterOSMF Group (n=30)Control Group (n=30)Gender (M/F)27 (90%)/3 (10%)27 (90%)/3 (10%)Mean age (years)24.50±1.6824.73±2.00Most common habitGutkha only (15 cases; 50%)Not applicableMost common site of fibrosisBuccal mucosa (100%)Not applicable Distribution of demographic and habitual variables in OSMF and control groups DISCUSSION Oral submucous fibrosis (OSMF) is a progressive, potentially malignant disorder characterized by juxtaepithelial fibrosis, restricted mouth opening, and a burning sensation, most commonly attributed to areca nut consumption.[1] The etiology is multifactorial, involving nutritional deficiencies, genetic predispositions, and autoimmune responses, all of which may contribute to systemic metabolic imbalances, including elevated homocysteine levels.[2] Homocysteine, a sulfur-containing amino acid, has been implicated in numerous pathological processes, such as oxidative stress, inflammation, and DNA damage, making it a candidate biomarker for precancerous and cancerous conditions.[3] The serum homocysteine concentrations of OSMF patients were highly raised compared to healthy ones, and it gradually rose with the different clinical stages and histopathological grade of this disorder in the current case-control research study. This implies the existence of a relationship between the level of disease severity and the disruption of metabolism.[4] The evidence supports the previous studies that described the existence of high homocysteine concentration in OSMF and other cancers, and this shows that this measure can help in predicting the path of the disease.[5] Poor food habits of these patients, which may include routine substance abuse and, hence, prompt the lack of nutritional values such as folate, vitamin B12, and vitamin B6 may also worsen hyperhomocysteinemia in such patients.[6] Mechanistically homocysteine high concentrations are expected to enhance oxidative DNA damage, disrupt the methylation cycle, in addition to forming reactive oxygen species (ROS), implicated in carcinogenesis.[78] CONCLUSION According to the present observations, serum homocysteine has the potential to be considered a prognostic biomarker sensitive to early oxidation of OSMF progression. Conflicts of interest There are no conflicts of interest.